Keyphrases
6-methylmercaptopurine
18%
Adenine Phosphoribosyltransferase
18%
Camptocormia
18%
Clinical Phenotype
21%
Clinical Trials
22%
Clinical Utility
18%
Congenital Myopathy
18%
Cytosolic 5′-nucleotidase 1A
18%
Dermatomyositis
33%
Disease Onset
21%
DNAJB4
18%
DNAJB6
68%
Duchenne muscular Dystrophy
100%
Duplication
22%
Dystrophin
59%
Dystrophinopathy
25%
Exome Sequencing
20%
Exon
36%
Exon Duplication
36%
Exon Skipping
26%
Gene Therapy
18%
Genetic Basis
27%
Heat Shock Protein 70 (HSP70)
25%
Idiopathic Inflammatory Myopathies
46%
Isoform-specific
18%
Knockdown
22%
Limb-girdle muscular Dystrophy
82%
Lithium Chloride
18%
Manifesting Carriers
18%
Missense mutation
25%
Mouse Model
24%
Multisystem Proteinopathy
21%
Muscle Disease
50%
Muscular Dystrophy
45%
Myopathology
22%
Myopathy
42%
Myotubes
19%
Natural History
18%
Patient-derived Cell Line
18%
Phenotypic Diversity
18%
Phenotypic Spectrum
18%
Polymyositis
21%
Respiratory Failure
18%
Skipping
36%
Tetrahymena
18%
Therapeutic Approaches
20%
Therapeutic Potential
20%
Treatment Strategy
22%
Valosin-containing Protein
18%
Z-domain
18%
Biochemistry, Genetics and Molecular Biology
Adenine
18%
Adenine Phosphoribosyltransferase
18%
Antisense
18%
ATPase
18%
Cas9
18%
Catenin
18%
Cell Death
9%
Chaperone (Protein)
9%
Clinical Trial
18%
Co-Chaperone
11%
Disease Burden
9%
Disease Registry
18%
Dystroglycan
15%
Dystrophin
49%
Exome Sequencing
27%
Exon
72%
Exon Skipping
17%
Fibroblast
12%
Fungal Cell Culture
9%
Genetic Carrier
18%
Genetics
24%
Genotyping
19%
Glycogen Synthase Kinase
18%
Grip Strength
18%
Heat Shock
9%
Heterozygote
18%
Immunoblotting
20%
Internal Ribosome Entry Site
18%
Isoform
39%
Isotope Labeling
18%
Knockout Mouse
9%
Mass Spectrometry
20%
Messenger RNA
14%
Missense
9%
Missense Mutation
20%
Mouse Model
52%
Mutant Protein
18%
Observational Study
9%
Oligonucleotide
18%
Paromomycin
12%
Proteinopathy
21%
Quality Control
18%
Reading Frame
12%
Rigidity
9%
RNAI
12%
Skeletal Muscle
38%
Small Molecule
18%
Tetrahymena
18%
Valosin-Containing Protein
18%
Wild Type
17%
Medicine and Dentistry
5' Nucleotidase
18%
Adenosine Triphosphatase
18%
Antisense Oligonucleotide
18%
Antisynthetase Syndrome
9%
Camptocormia
18%
Cell Line
18%
Clinical Feature
6%
Clinical Research
6%
Clinical Trial
6%
Cohort Effect
6%
Corticosteroid
6%
Dermatomyositis
27%
Diagnosis
9%
Disease
15%
Diseases
48%
Drive
6%
Duchenne Muscular Dystrophy
60%
Dystrophin
11%
Exome Sequencing
22%
Exon
36%
Exon Skipping
17%
Gene Therapy
12%
Genetic Screening
12%
Genotype Phenotype Correlation
5%
Haploinsufficiency
6%
Heterozygote
9%
Histopathology
10%
Immunity
9%
Immunosuppressive Drug
6%
Inclusion Body Myositis
18%
Limb Girdle Muscular Dystrophy
18%
Medicine
6%
Messenger RNA
14%
Muscle Biopsy
16%
Muscle Disease
12%
Muscle Weakness
10%
Muscular Dystrophy
18%
Myopathy
60%
Myositis
18%
Neuromuscular Disorder
6%
Nosology
6%
Onset Age
7%
Ophthalmoparesis
13%
Paget Bone Disease
5%
Patient Registry
7%
Polymyositis
18%
Skeletal Muscle
5%
Vacuolization
13%
Valosin Containing Protein
18%
Weakness
12%
